These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9160264)
1. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography. Toft KG; Friisk GA; Skotland T J Pharm Biomed Anal; 1997 Apr; 15(7):973-81. PubMed ID: 9160264 [TBL] [Abstract][Full Text] [Related]
2. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood. Toft KG; Kindberg GM; Skotland T J Pharm Biomed Anal; 1997 Apr; 15(7):983-8. PubMed ID: 9160265 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and pharmacokinetics of MnDPDP in man. Toft KG; Hustvedt SO; Grant D; Martinsen I; Gordon PB; Friisk GA; Korsmo AJ; Skotland T Acta Radiol; 1997 Jul; 38(4 Pt 2):677-89. PubMed ID: 9245963 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs. Toft KG; Hustvedt SO; Grant D; Friisk GA; Skotland T Eur J Drug Metab Pharmacokinet; 1997; 22(1):65-72. PubMed ID: 9179562 [TBL] [Abstract][Full Text] [Related]
5. Dephosphorylation of MnDPDP and related compounds by acid and alkaline phosphatase. Toft KG; Myrset AH; Skotland T J Pharm Biomed Anal; 2001 Jun; 25(3-4):613-8. PubMed ID: 11377042 [TBL] [Abstract][Full Text] [Related]
6. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR. Schmidt PP; Toft KG; Skotland T; Andersson K J Biol Inorg Chem; 2002 Mar; 7(3):241-8. PubMed ID: 11935348 [TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Karlsson JO; Brurok H; Eriksen M; Towart R; Toft KG; Moen O; Engebretsen B; Jynge P; Refsum H Acta Radiol; 2001 Nov; 42(6):540-7. PubMed ID: 11736698 [TBL] [Abstract][Full Text] [Related]
9. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue. Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754 [TBL] [Abstract][Full Text] [Related]
10. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Wang C Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956 [TBL] [Abstract][Full Text] [Related]
11. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate--, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart. Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P Invest Radiol; 1995 Mar; 30(3):159-67. PubMed ID: 7797414 [TBL] [Abstract][Full Text] [Related]
12. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks]. Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779 [TBL] [Abstract][Full Text] [Related]
13. Cardiac metal contents after infusions of manganese. An experimental evaluation in the isolated rat heart. Brurok H; Berg K; Sneen L; Grant D; Karlsson JO; Jynge P Invest Radiol; 1999 Jul; 34(7):470-6. PubMed ID: 10399637 [TBL] [Abstract][Full Text] [Related]
15. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique. Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926 [TBL] [Abstract][Full Text] [Related]
16. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts. Brurok H; Skoglund T; Berg K; Skarra S; Karlsson JO; Jynge P NMR Biomed; 1999 Oct; 12(6):364-72. PubMed ID: 10516618 [TBL] [Abstract][Full Text] [Related]
18. Determination of mangafodipir trisodium and related impurities in bulk substance and pharmaceutical formulation by ion-pair high-performance liquid chromatography. Gjerde H; Snøtun A; Hem H; Larsen KH; Døhl J J Pharm Biomed Anal; 2001 Apr; 25(1):109-14. PubMed ID: 11274864 [TBL] [Abstract][Full Text] [Related]
19. Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction. Karlsson JE; El-Saadi W; Ali M; Puskar W; Skogvard P; Engvall JE; Andersson RG; Maret E; Jynge P Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):39-45. PubMed ID: 27533964 [TBL] [Abstract][Full Text] [Related]
20. Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities. Ni Y; Marchal G Acta Radiol; 1997 Jul; 38(4 Pt 2):724-31. PubMed ID: 9245968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]